Kura Oncology (KURA) Receivables - Other (2014 - 2020)
Kura Oncology's Receivables - Other was $31,000 in Q1 2020, down 82.7% from $179,000 a year earlier but up 3.3% from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Receivables - Other (2014 - 2020) Analysis & Trends
At the end of FY2019, Receivables - Other at Kura Oncology came in at $30,000, down 86.6% from FY2018.
- Receivables - Other shows a five-year compound annual growth rate of 0.0% (FY2014 to FY2019).
- In earlier years, Receivables - Other was $224,000 in FY2018 (+3.7%), $216,000 in FY2017 (-26.8%), $295,000 in FY2016 (-31.4%) and $430,000 in FY2015.
- Quarterly Receivables - Other has moved between $30,000 (Q4 2019) and $430,000 (Q4 2015) over five years.
- Compared with a year earlier, Receivables - Other has declined for five straight quarters, with an average decline of 42.6% over the last eight quarters.
- The best year-over-year quarter for Receivables - Other over five years was Q1 2016 (growth of 16.3%); the worst was Q4 2019 (a decline of 86.6%).
- Per Business Quant data, KURA's Receivables - Other in the three quarters before Q1 2020 was $30,000 (Q4 2019), $47,000 (Q3 2019) and $111,000 (Q2 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kura Oncology | 952.70 Mn | 952.70 Mn | 20.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 31,000.00 |
| Dec 31, 2019 | 30,000.00 |
| Sep 30, 2019 | 47,000.00 |
| Jun 30, 2019 | 111,000.00 |
| Mar 31, 2019 | 179,000.00 |
| Dec 31, 2018 | 224,000.00 |
| Sep 30, 2018 | 232,000.00 |
| Jun 30, 2018 | 230,000.00 |
| Mar 31, 2018 | 257,000.00 |
| Dec 31, 2017 | 216,000.00 |
| Sep 30, 2017 | 209,000.00 |
| Jun 30, 2017 | 304,000.00 |
| Mar 31, 2017 | 341,000.00 |
| Dec 31, 2016 | 295,000.00 |
| Sep 30, 2016 | 261,000.00 |
| Jun 30, 2016 | 286,000.00 |
| Mar 31, 2016 | 406,000.00 |
| Dec 31, 2015 | 430,000.00 |
| Sep 30, 2015 | 379,000.00 |
| Jun 30, 2015 | 372,000.00 |
API Access
Kura Oncology Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();